Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01862497 · ClinicalTrials.gov registry record
Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 76
- Enrollment target
NCT01862497 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 76 participants.
The verdict
NCT01862497 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is 1) to determine what physiologic factors (extracellular fluid overload or vasoconstriction) contribute more to increased blood pressure levels between dialysis treatments in hemodialysis patients whose blood pressure increases and decreases during hemodialysis and 2) to determine whether carvedilol provides better control of blood pressure between dialysis treatments than prazosin in patients whose blood pressure increases during dialysis.
Interventions
- DRUG Carvedilol vs. Prazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01862497
The ClinicalTrials.gov registry entry for NCT01862497 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carvedilol vs. Prazosin is the first listed.
NCT01862497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01862497 about?
NCT01862497 is a clinical study titled "Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension". The purpose of this study is 1) to determine what physiologic factors (extracellular fluid overload or vasoconstriction) contribute more to increased blood pressure levels between dialysis treatments in hemodialysis patients whose blood pressure increases and decreases during hemodialysis and 2) to ...
What is the current status of trial NCT01862497?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2013-01. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01862497?
The interventions under investigation include: Carvedilol vs. Prazosin (DRUG).
Who is sponsoring clinical trial NCT01862497?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.